Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
American Journal of Obstetrics and Gynecology
|
May 1, 1993
Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine
L A Cole, D B Seifer, A Kardana, et al.
Gynecologic Oncology
|
March 1, 1990
Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass
L A Cole, J H Nam, J T Chambers, et al.
Arthritis and Rheumatism
|
December 1, 1987
Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V
A R Cabral, L A Cole, D A Walz, et al.
Gynecologic Oncology
|
December 1, 1990
Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors
J H Nam, J T Chambers, P E Schwartz, et al.
Molecular Medicine Today
|
April 14, 1999
Urinary analyte screening: a noninvasive detection method for Down syndrome?
J A Canick, L H Kellner, L A Cole, et al.
Protein Engineering
|
April 9, 1999
Mutation of a highly conserved aspartate residue in subdomain IX abolishes Fer protein-tyrosine kinase activity
L A Cole, R Zirngibl, A W Craig, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 6, 2004
HCG urinary metabolites in breast milk
J M Sutton, S A Khanlian, L A Cole, et al.
Endocrinology
|
September 1, 1983
Detection of the free beta subunit of human chorionic gonadotropin (HCG) in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma
L A Cole, R J Hartle, J J Laferla, et al.
Prenatal Diagnosis
|
May 1, 1997
Screening for Down syndrome pregnancy using beta-core fragment: prospective study
T Isozaki, G E Palomaki, R O Bahado-Singh, et al.
Gynecologic Oncology
|
March 1, 1990
Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity
J H Nam, L A Cole, J T Chambers, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
American Journal of Obstetrics and Gynecology
|
May 1, 1993
Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine
L A Cole, D B Seifer, A Kardana, et al.
Gynecologic Oncology
|
March 1, 1990
Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass
L A Cole, J H Nam, J T Chambers, et al.
Arthritis and Rheumatism
|
December 1, 1987
Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V
A R Cabral, L A Cole, D A Walz, et al.
Gynecologic Oncology
|
December 1, 1990
Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors
J H Nam, J T Chambers, P E Schwartz, et al.
Molecular Medicine Today
|
April 14, 1999
Urinary analyte screening: a noninvasive detection method for Down syndrome?
J A Canick, L H Kellner, L A Cole, et al.
Protein Engineering
|
April 9, 1999
Mutation of a highly conserved aspartate residue in subdomain IX abolishes Fer protein-tyrosine kinase activity
L A Cole, R Zirngibl, A W Craig, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 6, 2004
HCG urinary metabolites in breast milk
J M Sutton, S A Khanlian, L A Cole, et al.
Endocrinology
|
September 1, 1983
Detection of the free beta subunit of human chorionic gonadotropin (HCG) in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma
L A Cole, R J Hartle, J J Laferla, et al.
Prenatal Diagnosis
|
May 1, 1997
Screening for Down syndrome pregnancy using beta-core fragment: prospective study
T Isozaki, G E Palomaki, R O Bahado-Singh, et al.
Gynecologic Oncology
|
March 1, 1990
Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity
J H Nam, L A Cole, J T Chambers, et al.
Page
of 12